BTIG Reiterates Buy on GeneDx Holdings, Maintains $85 Price Target
BTIG analyst Mark Massaro reiterates GeneDx Holdings (NASDAQ:WGS) with a Buy and maintains $85 price target.
Last updated: 2026-11-19 07:45:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
GeneDx Holdings Corp. (WGS) operates in the SERVICES-HEALTH SERVICES sector and is listed on NASDAQ. The stock is currently priced at $51.96, with a market capitalization of $1.42B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $32.21 to $170.87. This page covers its latest market performance, valuation, price trends and company information.
$1.42B | |
$46.47 | |
$53.27 | |
$42.90 | |
$47.29 | |
1.49M | |
863.33K | |
-- | |
$170.87 | |
$32.21 | |
-- | |
2026-09-30 |
GeneDx Holdings Corp. (WGS) last closed at $51.96 as of 2026-11-19 00:31:00, up 9.85% ($4.66) from the previous close of $47.29.
During the latest regular trading session, WGS traded between $42.90 and $53.27, with a volume of 1.49M shares. The closing price was near the upper end and near the lower end of its 52-week range.
WGS is up 9.85% as of the last close.
Over the past seven days, GeneDx Holdings Corp. (WGS) moved from $54.83 to $51.96, representing a decline of 5.23% ($2.87).
The stock traded between $42.90 and $59.72 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 1.60 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 14.2%
WGS is currently trading at $51.96, placing it 14.2% of the way from its 52-week low of $32.21 to its 52-week high of $170.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
| Industry | SERVICES-HEALTH SERVICES |
| Employees | 1,300 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to GeneDx Holdings Corp. and WGS stock.
BTIG analyst Mark Massaro reiterates GeneDx Holdings (NASDAQ:WGS) with a Buy and maintains $85 price target.
GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $482.324 million estimate.
Eligible investors can buy real shares of GeneDx Holdings Corp. (WGS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to WGS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between WGS shares and USD.
WGS Shares to USD
1.00 WGS shares = 51.96 USD
Calculations are estimates based on the latest available price and are for reference only.